Alphatec Holdings, Inc. Drives Spinal Disorder Solution Technology and Announces the Launch of the New CONNECT II Cervical Structural Allograft Product

CARLSBAD, Calif., May 15, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today the release of the CONNECT(r) II Cervical Structural Allograft spacer. The CONNECT II product is integrated with Alphatec’s proprietary cervical fusion instrumentation for maximum ease of use, procedural efficiency and further completes Alphatec’s cervical fusion product line.

MORE ON THIS TOPIC